Lilly Hits $1 Trillion Valuation with Weight-Loss Success
Eli Lilly hits $1 trillion valuation, marking a historic milestone in the pharmaceutical industry with successful weight-loss drugs.
Lenacapavir in Short Supply Amid HIV Epidemic in Africa
Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.
Trade Tariffs and Their Impact on Pharmaceuticals
Explore the impact of trade tariffs on the pharmaceutical industry with the new EU-US trade deal imposing up to 15% tariffs.